Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Measuring HCV Intervention Success

J Viral Hepat; ePub 2018 Feb 27; Harris, et al

Biomedical innovation alone is not sufficient to increase hepatitis C virus (HCV) treatment engagement among patients most marginalized, with sustainable resourcing of community services crucial in order to effect changes, a recent study found. This intervention from the HepCATT study comprised multiple components, including a nurse facilitator, peer support, and education initiatives. The 96 participants comprised drug service and intervention providers and clients with injecting history. Researchers found:

  • Client engagement with a HCV treatment service rose from 16 at baseline in 2014 to 147 in 2016.
  • Baseline testing and treatment barriers included limited HCV knowledge, fear of diagnosis and treatment, precarious living circumstances, and service-specific obstacles.
  • Treatment engagement was aided by intervention timeliness, improved communication structures, personalized care, streamlined testing and treatment pathways, and peer support.
  • The nurse practitioner was key to intervention success.


Harris M, Bonnington O, Harrison G, Hickman M, Irving W; on behalf of the HepCATT team. Understanding hepatitis C intervention success—Qualitative findings from the HepCATT study. [Published online ahead of print February 27, 2018]. J Viral Hepat. doi:10.1111/jvh.12869.

This Week's Must Reads

CVD Events Prevented with New AHA BP Guideline, Circulation; ePub 2018 Nov 19; Bress, et al

USPSTF: Interventions to Prevent Child Maltreatment, JAMA; 2018 Nov 27; US Preventive Services Task Force

Team-Based Primary Care in Chronically Ill Patients, JAMA Intern Med; ePub 2018 Nov 26; Meyers, et al

Rotating Night Shift Work & Risk of T2D, BMJ; ePub 2018 Nov 21; Shan, Li, et al

PUFAs for Primary & Secondary CVD Prevention, Cochrane Library; ePub 2018 Nov 27; Abdelhamid, et al

Must Reads in Hepatitis

Glecaprevir/Pibrentasvir in HCV GT 3 Infection, J Viral Hepat; ePub 2018 Nov 12; Flamm, et al

HCV Therapy Reduces CVD Events in Veterans, Gastroenterology; ePub 2018 Nov 13; Butt, et al

Alcohol Use Disorder in Patients with HCV/HIV , Drug Alcohol Depend; 2018 Oct 30; Frost, et al

Sexually-acquired HCV in MSM Using PrEP, J Infect Dis; ePub 2018 Nov 20; Price, et al

Effective HCV Testing In US Prisons, Am J Prev Med; ePub 2018 Nov 19; Assoumou, et al